Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial
infarction: collaborative overview of early mortality and major morbidity
results from all randomised trials of more than 1000 patients. Lancet.1994;343:311-322.
White HD, Van de Werf FJJ. Thrombolysis for acute myocardial infarction. Circulation.1998;97:1632-1646.
Gruppo Italiano Per Studio Della Streptochinasi Nell'Infarcto Miocardico
(GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial
Wennerblom B. Early mortality from ischemic heart disease and the effect of mobile
coronary care. Acta Med Scand.1982;667:1-58.
Cummins R. Advanced Cardiac Life Support. Dallas, Tex: American Heart Association; 1997.
Kereiakes DJ, Weaver WD, Anderson JL.
et al. Time delays in the diagnosis and treatment of acute myocardial infarction:
a tale of eight cities: report from the Pre-hospital Study Group and the Cincinnati
Heart Project. Am Heart J.1990;120:773-780.
McGovern PG, Pankow JS, Shahar E.
et al. Recent trends in acute coronary heart disease mortality, morbidity,
medical care and risk factors. N Engl J Med.1996;334:884-890.
Goff DC, Nichaman MZ, Ramsey DJ, Meyer PS, Labarthe DR. A population-based assessment of the use and effectiveness of thrombolytic
therapy: the Corpus Christi Heart Project. Ann Epidemiol.1995;5:171-178.
Luepker RV, Murray DM, Jacobs Jr DR.
et al. Community education for cardiovascular disease prevention: risk factor
changes in the Minnesota Heart Health Program. Am J Public Health.1994;84:1383-1393.
Farquhar JW, Fortmann SP, Flora JA.
et al. Effects of community-wide education on cardiovascular disease risk
factors: the Stanford Five-City Project. JAMA.1990;264:359-365.
Puska P, Tuomilehto J, Nissinen A, Vartiainen E. The North Karelia Project: 20 Year Results and Experiences. Helsinki, Finland: Helsinki University Printing House; 1995.
Simons-Morton DG, Goff DC, Osganian S.
et al. for the REACT Research Group. Rapid early action for coronary treatment: rationale, design, and baseline
characteristics. Acad Emerg Med.1998;5:656-658.
Raczynski JM, Finnegan JR, Zapka JG.
et al. REACT theory-based intervention to reduce treatment-seeking delay for
acute MI. Am J Prev Med.1999;16:325-224.
Bandura A. Social Foundations of Thought and Action: a Social
Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
Perry CL, Baranowski T, Parcel GS. How individuals, environments, and health behavior interact: social
learning theory. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior
and Health Education: Theory Research and Practice. San Francisco,
Calif: Jossey-Bass; 1990:161-186.
Leventhal H. Emotional and behavioural processes. In: Johnston M, Wallace L, eds. Stress and Medical
Procedures. Oxford, England: Oxford University Press; 1990:25-57.
Rogers EM. Diffusion of Innovations. 3rd ed. New York, NY: The Free Press; 1983.
Novelli WD. Developing marketing programs. In: Frederiksen LW, Solomon LJ, Brehony KA, eds. Marketing Health Behavior: Principles, Techniques and Application.
New York, NY: Plenum Press; 1984:59-89.
Lefebvre RC, Rochlin L. Social marketing. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior
and Health Education: Theory, Research and Practice. San Francisco,
Calif: Jossey-Bass; 1997:384-402.
Bracht N, Gleason J. Strategies and structures for citizen partnerships. In: Bracht N, ed. Health Promotion at the Community
Level. Newbury Park, Calif: Sage Publications Inc; 1990:109-124.
Bracht N, Finnegan Jr JR, Rissel C.
et al. Community ownership and program continuation following a health demonstration
project. Health Educ Res.1994;9:243-255.
Feldman HA, Proschan MA, Murray DM.
et al. Statistical design of REACT (Rapid Early Action for Coronary Treatment):
a multi-site community trial with continual data collection. Control Clin Trials.1998;19:391-403.
Murray DM. Design and Analysis of Group-Randomized Trials. New York, NY: Oxford University Press; 1998:426-430.
Goff DC, Feldman HA, McGovern PG.
et al. Pre-hospital delay in patients hospitalized with heart attack symptoms
in the United States: the REACT Trial. Am Heart J.1999;138:1046-1057.
Gail MH, Mark SD, Carroll RJ, Green SB, Pee D. Design considerations and randomization-based inference for community
intervention trials. Stat Med.1996;15:1069-1092.
Newby LK, Rutsch WR, Califf RM.
et al. for the GUSTO-1 Investigators. Time from symptom onset to treatment and outcomes after thrombolytic
therapy. J Am Coll Cardiol.1996;27:1646-1655.
Sharkey SW, Bruneete DD, Ruiz E.
et al. An analysis of time delays preceding thrombolysis for acute myocardial
The Task Force on the Management of Acute Myocardial Infarction of
the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J.1996;17:43-63.
Hand M, Brown C, Horan M, Simons-Morton D.on behalf of the National Heart Attack Alert Program. The National Heart Attack Alert Program: progress at 5 years in educating
providers, patients and the public and future directions. J Thromb Thrombolysis.1998;6:9-17.
Meischke H, Eisenberg M, Larsen MP. Pre-hospital delay interval for patients who use emergency medical
services: the effect of heart-related medical conditions and demographic variables. Ann Emerg Med.1993;22:1597-1601.
Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence
on outcome. J Am Coll Cardiol.1995;25(7 suppl):3S-9S.
Bolte HD. Coronary heart disease: new therapeutic developments. Heartbeat.1987;4:4-5.
Cooper RS, Simmons B, Castaner A, Prasad R, Franklin C, Ferlina J. Survival rates and pre-hospital delay during myocardial infarction
among black persons. Am J Cardiol.1986;57:208-211.
Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK. Delay between onset of chest pain and seeking medical care: the effect
of public education. Ann Emerg Med.1989;18:727-731.
Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends and factors associated with extent of delay to hospital
arrival in patients with acute myocardial infarction: the Worcester Heart
Attack Study. Am Heart J.1994;128:255-263.
Goldberg RJ, McGovern PG, Guggina T, Savageau J, Rosamond WD, Luepker RV. Pre-hospital delay in patients with acute coronary heart disease: concordance
between patient interviews and medical records. Am Heart J.1998;135:293-299.
Ridker PM, Manson JE, Goldhaber SZ, Hennekens CH, Buring JE. Comparison of delay times to hospital presentation for physicians and
nonphysicians with acute myocardial infarction. Am J Cardiol.1992;70:10-13.
Gaspoz JM, Unger PF, Urban P.
et al. Impact of a public campaign on pre-hospital delay in patients reporting
chest pain. Heart.1996;76:150-155.
Mitic WR, Perkins J. The effect of a media campaign on heart attack delay and decision times. Can J Public Health.1984;75:414-418.
Herlitz J, Blohm M, Hartford M.
et al. Follow-up of a 1-year media campaign on delay times and ambulance use
in suspected acute myocardial infarction. Eur Heart J.1992;13:171-177.
Bett N, Aroney G, Thompson P. Impact of a national educational campaign to reduce patient delay in
possible heart attack. Aust N Z J Med.1993;23:157-161.
Moses HW, Engelking N, Taylor GJ.
et al. Effect of a two-year public education campaign on reducing response
time of patients with symptoms of acute myocardial infarction. Am J Cardiol.1991;68:249-251.
Goff DC, Sellers DE, McGovern PG.
et al. for the REACT Study Group. Knowledge of heart attack symptoms in a population survey in the United
States: The REACT Trial. Arch Intern Med.1998;158:2329-2338.